1. Home
  2. Stock quotes
  3. Affimed N.V.
  4. Financial Ratios
  5. P/S Ratio
Affimed N.V. logo
Affimed N.V. AFMD

Quarterly report 2022-Q2
added 08-11-2022

report update icon

Affimed N.V. P/S Ratio 2011-2026 | AFMD

Annual P/S Ratio Affimed N.V.

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
11.8 11 6.84 7.24 25 8.27 12.4 34.3 - - -

All numbers in EUR currency

Indicator range from annual reports

Maximum Minimum Average
34.3 6.84 14.6

P/S Ratio of other stocks in the Biotechnology industry

Issuer P/S Ratio Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
 		1.75 - 2.43 % $ 254 M germanyGermany
Aeterna Zentaris Aeterna Zentaris
AEZS
 		7.87 - 5.93 % $ 314 M canadaCanada
Albireo Pharma Albireo Pharma
ALBO
 		13.3 - -0.23 % $ 916 M usaUSA
I-Mab I-Mab
IMAB
 		94.1 - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
 		5.53 - - $ 40.3 B usaUSA
Genfit SA Genfit SA
GNFT
 		1.96 K - 2.54 % $ 160 B franceFrance
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
 		947 $ 219.68 1.92 % $ 5 B danmarkDanmark
Aptinyx Aptinyx
APTX
 		204 - -39.0 % $ 4.57 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
 		137 - -18.52 % $ 27.3 M britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
 		2.39 K - -1.52 % $ 24.7 M usaUSA
Seres Therapeutics Seres Therapeutics
MCRB
 		1.08 $ 8.28 - $ 1.06 B usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
 		1.73 $ 19.45 1.14 % $ 909 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
 		65.5 - - $ 26.5 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
 		11.2 - - $ 7.46 M israelIsrael
AgeX Therapeutics AgeX Therapeutics
AGE
 		0.099 - -10.17 % $ 12.2 K usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
 		0.142 - -24.86 % $ 820 K usaUSA
Mesoblast Limited Mesoblast Limited
MESO
 		127 $ 15.44 7.82 % $ 10 B australiaAustralia
Acasti Pharma Acasti Pharma
ACST
 		0.203 - 4.01 % $ 150 M canadaCanada
BeiGene, Ltd. BeiGene, Ltd.
BGNE
 		66.4 - 0.49 % $ 251 B cayman-islandsCayman-islands
bluebird bio bluebird bio
BLUE
 		2.27 - - $ 546 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
 		2.61 - - - russiaRussia
Cara Therapeutics Cara Therapeutics
CARA
 		2.58 - -3.03 % $ 260 M usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
 		76.4 - - $ 86.2 M usaUSA
Acer Therapeutics Acer Therapeutics
ACER
 		25.8 - 2.71 % $ 14 M usaUSA
Advaxis Advaxis
ADXS
 		144 - -9.65 % $ 45.9 M usaUSA
CollPlant Biotechnologies Ltd. CollPlant Biotechnologies Ltd.
CLGN
 		10.4 $ 0.67 -5.25 % $ 7.67 M israelIsrael
Mirum Pharmaceuticals Mirum Pharmaceuticals
MIRM
 		10.4 $ 90.39 2.86 % $ 4.54 B usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
 		1.37 K $ 1.34 1.52 % $ 342 M britainBritain
MediciNova MediciNova
MNOV
 		169 $ 1.45 - $ 71.1 M usaUSA
CytomX Therapeutics CytomX Therapeutics
CTMX
 		12.2 $ 4.37 2.95 % $ 603 M usaUSA
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCC
 		130 - -5.98 % $ 34.1 M usaUSA
ChemoCentryx ChemoCentryx
CCXI
 		0.0564 - - $ 3.74 B usaUSA
Aytu BioScience Aytu BioScience
AYTU
 		0.237 $ 2.69 1.37 % $ 16.9 M usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
 		6.24 - - $ 2.02 B usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
 		1.85 - -4.8 % $ 255 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
 		489 - - $ 1.01 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
 		281 - - $ 867 M germanyGermany
Merck & Co. Merck & Co.
MRK
 		4.78 $ 117.56 1.02 % $ 294 B usaUSA
Marker Therapeutics Marker Therapeutics
MRKR
 		5.78 $ 1.37 8.73 % $ 21 M usaUSA
Moderna Moderna
MRNA
 		9.99 $ 53.09 3.41 % $ 20.7 B usaUSA
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
 		60.1 $ 4.47 3.71 % $ 856 M canadaCanada
Homology Medicines Homology Medicines
FIXX
 		23.8 - 0.77 % $ 53.4 M usaUSA